A Norwegian randomized controlled trial shows that a single screening sigmoidoscopy reduces colorectal cancer risk for over 20 years. The benefit was more pronounced in men than women.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Single screening sigmoidoscopy linked to lower colorectal cancer risk two decades later

20+ Years Follow-Up Study duration
Single Sigmoidoscopy Sustained Reduction Cancer prevention effect
Men Showed Greater Benefit Than Women Gender difference
Women Saw More Modest Reduction gender difference
20+ Years cancer risk reduction duration